Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     Neurology Devices Market     Nerve Repair & Regeneration Market     Global Neurostimulation/Neuromodulation Market     Global Internal Neurostimulation Market    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

European Internal Neurostimulation Market

  • Report Code: IN 1001
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The European internal neurostimulation devices market is mainly driven by rapidly aging population and associated diseases like Alzheimer’s, epilepsy, spinal cord injury, and Parkinson’s disease. The European internal neurostimulation market was $947.8 million in 2013, and is expected to reach $1715.8 million by 2018 at a CAGR of 13.0%. The internal neuromodulation market was the largest segment constituting 87% of the overall neurostimulation market.

 

The report ‘The European Internal Neurostimulation Devices Market forecast, 2012-2018’ analyzes internal neurostimulation market segmented by modalities including spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), and gastric electrical stimulation (GES), and by applications such as chronic pain, failed back surgery syndrome, refractory angina pectoris, peripheral neuropathy, Alzheimer’s, Dystonia, Tourette’s Syndrome, Parkinson’s, epilepsy, fecal incontinence, and urine incontinence and gastroparesis.

 

These segments experienced a positive growth until 2012, with an increased awareness for procedures and sophisticated diagnostic techniques. With a market value of $2.3 and $0.6 billion, the spinal cord stimulation (SCS) and deep brain stimulation (DBS) segments contributed 51% and 14%, in terms of value, towards the total internal neurostimulation device market. Both the markets have been witnessing high growth because of the increase in patient pool and procedure numbers of the various modalities.

 

Procedure volume growth is significantly higher in BIC (Brazil, India, China) and Mexico because of fast disease progression, higher prevalence, improving healthcare infrastructure, economic growth, broadening insurance coverage, expanding private healthcare sector, and increasing awareness amongst people.

  

The prevalence of Alzheimer’s in North America and Europe is around 5.4-6.4% in adult population whereas in Asia, it is around 4%. The incidences of Alzheimer’s were 411,000 in 2000. This number increased to 454,000 in 2010, and is expected to reach 615,000 by 2030 and 959,000 by 2050. Such high incidence rates in neurological disorders will positively affect the market for neuromodulation.

 

The report also provides an extensive competitive landscaping of companies operating in the European internal neurostimulation market. Major players dominating the European internal neurostimulation market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S.), and Neuronetics, Inc. (U.S.) Emerging players in this market include Biocontrol Medical, ANM Neuromodulation GmbH, and Magstim Company Limited.

 

Segment and country-specific company shares, news & deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.

 

Customization Options

Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:

  • Product Analysis
    • Usage pattern (in-depth trend analysis) of products (segment wise)
    • Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
    • End-user adoption rate analysis of the products (segment wise and country wise)
    • Comprehensive coverage of product approvals, pipeline products, and product recalls

 

  • Epidemiology Data
    • Country-specific prevalence of Alzheimer’s ,Parkinson’s, epilepsy and stroke
    • Country-specific incidence of Alzheimer’s, Parkinson’s, epilepsy, stroke
    • Country-specific mortality rate of stroke and epilepsy
    • Country-specific patient pool of Alzheimer’s, Parkinson’s, epilepsy and stroke
    • Disease progression (pattern analysis)

 

  • Procedure Volume Data
    • Country-wise number of surgeries for epilepsy, heart failure, Alzheimer’s, and Parkinson’s

 

  • Surgeons/Physicians Perception analysis
    • Fast turn-around analysis of surgeons’ response to market events and trends
    • Pattern analysis of usage of spinal cord stimulation (SCS) and deep brain stimulation (DBS) by physicians
    • Surgeons’ opinion about products from different companies
    • Surgeons’ qualitative inputs on epidemiology data

 

  •  Brand/Product Perception Matrix
    • Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
    • Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)

 

  • Pricing Trends
    • Cost analysis of the European internal neurostimulation devices
    • The European internal neurostimulation procedural investment

 

  • Competitive Intelligence
    • The company share analysis for the top players of this market in Europe
    • The crucial developments and strategies of the companies inculcated in their portfolio of the European internal neurostimulation market


1 Introduction

1.1 Introduce the Market

1.2 Objective of the study

1.3 Market Definition and Scope of the study

1.3.1 Market Definition

1.3.2 Areas covered

1.3.3 Markets Covered

1.4 Stakeholders

1.5 Research Methodology

1.5.1 Secondary sources

1.5.2 Primary Sources

1.5.3 Market estimation methodology (Top-down, bottom-up, data triangulation.)

1.5.4 Macro indicators for the study

1.6 Assumptions

1.7 List of Acronyms

2 Market Overview

3 Internal Neurostimulation-Europe, By SurgeryProcedures

3.1 Split By Geography

3.2 Internal Neurostimulation-Europe-Direct Nerve Repair

3.2.1 Internal Neurostimulation-Europe-Direct Nerve Repair, By Geographies

3.2.1.1 Internal Neurostimulation-United Kingdom-Direct Nerve Repair

3.2.1.2 Internal Neurostimulation-France-Direct Nerve Repair

3.3 Internal Neurostimulation-Europe-Nerve Grafting

3.3.1 Internal Neurostimulation-Europe-Nerve Grafting, By Geographies

3.3.1.1 Internal Neurostimulation-United Kingdom-Nerve Grafting

3.3.1.2 Internal Neurostimulation-France-Nerve Grafting

3.4 Internal Neurostimulation-Europe-Stem cell therapy

3.4.1 Internal Neurostimulation-Europe-Stem cell therapy, By Geographies

3.4.1.1 Internal Neurostimulation-United Kingdom-Stem cell therapy

4 Internal Neurostimulation-Europe, By Types

4.1 Split By Geography

4.2 Spinal cord stimulator-Europe

4.2.1 Spinal cord stimulator-Europe, By Applications

4.2.1.1 Spinal cord stimulator-Chronic Pain-Europe

4.2.1.2 Spinal cord stimulator-Spinal Cord Injury-Europe

4.2.1.3 Spinal cord stimulator-Ischemic heart disease-Europe

4.2.1.4 Spinal cord stimulator-Others-Europe

4.2.2 Spinal cord stimulator-Europe, By Geographies

4.2.2.1 Spinal cord stimulator-United Kingdom

4.2.2.2 Spinal cord stimulator-France

4.2.2.3 Spinal cord stimulator-Germany

4.2.2.4 Spinal cord stimulator-Italy

4.2.2.5 Spinal cord stimulator-Spain

4.2.2.6 Spinal cord stimulator-Europe - Europe - Other Geographies

4.3 Deep Brain Stimulator-Europe

4.3.1 Deep Brain Stimulator-Europe, By Applications

4.3.1.1 Deep Brain Stimulator-Parkinson’s Disease-Europe

4.3.1.2 Deep Brain Stimulator-Other Applications-Europe

4.3.1.3 Deep Brain Stimulator-Coma and Brain Death-Europe

4.3.1.4 Deep Brain Stimulator-Depression-Europe

4.3.2 Deep Brain Stimulator-Europe, By Geographies

4.3.2.1 Deep Brain Stimulator-United Kingdom

4.3.2.2 Deep Brain Stimulator-France

4.3.2.3 Deep Brain Stimulator-Germany

4.3.2.4 Deep Brain Stimulator-Italy

4.3.2.5 Deep Brain Stimulator-Spain

4.3.2.6 Deep Brain Stimulator-Europe - Europe - Other Geographies

4.4 Sacral Nerve Stimulator-Europe

4.4.1 Sacral Nerve Stimulator-Europe, By Applications

4.4.1.1 Sacral Nerve Stimulator-Urine Incontinence-Europe

4.4.1.2 Sacral Nerve Stimulator-Fecal Incontinence-Europe

4.4.2 Sacral Nerve Stimulator-Europe, By Geographies

4.4.2.1 Sacral Nerve Stimulator-United Kingdom

4.4.2.2 Sacral Nerve Stimulator-France

4.4.2.3 Sacral Nerve Stimulator-Germany

4.4.2.4 Sacral Nerve Stimulator-Italy

4.4.2.5 Sacral Nerve Stimulator-Spain

4.4.2.6 Sacral Nerve Stimulator-Europe - Europe - Other Geographies

4.5 Vagus Nerve Stimulator-Europe

4.5.1 Vagus Nerve Stimulator-Europe, By Applications

4.5.1.1 Vagus Nerve Stimulator-Epilepsy-Europe

4.5.1.2 Vagus Nerve Stimulator-Other Applications-Europe

4.5.2 Vagus Nerve Stimulator-Europe, By Geographies

4.5.2.1 Vagus Nerve Stimulator-United Kingdom

4.5.2.2 Vagus Nerve Stimulator-France

4.5.2.3 Vagus Nerve Stimulator-Germany

4.5.2.4 Vagus Nerve Stimulator-Italy

4.5.2.5 Vagus Nerve Stimulator-Spain

4.5.2.6 Vagus Nerve Stimulator-Europe - Europe - Other Geographies

4.6 Gastric Electrical stimulator-Europe

4.6.1 Gastric Electrical stimulator-Europe, By Applications

4.6.1.1 Gastric Electrical stimulator-Gastroparesis-Europe

4.6.1.2 Gastric Electrical stimulator-Others-Europe

4.6.2 Gastric Electrical stimulator-Europe, By Geographies

4.6.2.1 Gastric Electrical stimulator-United Kingdom

4.6.2.2 Gastric Electrical stimulator-France

4.6.2.3 Gastric Electrical stimulator-Germany

4.6.2.4 Gastric Electrical stimulator-Italy

4.6.2.5 Gastric Electrical stimulator-Spain

4.6.2.6 Gastric Electrical stimulator-Europe - Europe - Other Geographies

5 Internal Neurostimulation-Europe, By Geographies

5.1 Internal Neurostimulation-United Kingdom

5.1.1 Internal Neurostimulation-United Kingdom, By Companies

5.1.1.1 Internal Neurostimulation-United Kingdom-Medtronic, Inc.

5.1.1.2 Internal Neurostimulation-United Kingdom-St. Jude Medical, Inc.

5.1.1.3 Internal Neurostimulation-United Kingdom-Other Companies

5.1.1.4 Internal Neurostimulation-United Kingdom-Boston Scientific

5.1.1.5 Internal Neurostimulation-United Kingdom-Cyberonics

5.1.1.6 Internal Neurostimulation-United Kingdom-Biocontrol Medical

5.1.1.7 Internal Neurostimulation-United Kingdom-Johnson & Johnson

5.1.1.8 Internal Neurostimulation-United Kingdom-Greatbatch Inc

5.1.2 Internal Neurostimulation-United Kingdom, By SurgeryProcedures

5.1.2.1 Internal Neurostimulation-United Kingdom-Direct Nerve Repair

5.1.2.2 Internal Neurostimulation-United Kingdom-Nerve Grafting

5.1.2.3 Internal Neurostimulation-United Kingdom-Stem cell therapy

5.1.3 Internal Neurostimulation-United Kingdom, By Types

5.1.3.1 Spinal cord stimulator-United Kingdom

5.1.3.2 Deep Brain Stimulator-United Kingdom

5.1.3.3 Sacral Nerve Stimulator-United Kingdom

5.1.3.4 Vagus Nerve Stimulator-United Kingdom

5.1.3.5 Gastric Electrical stimulator-United Kingdom

5.2 Internal Neurostimulation-France

5.2.1 Internal Neurostimulation-France, By Companies

5.2.1.1 Internal Neurostimulation-France-Medtronic, Inc.

5.2.1.2 Internal Neurostimulation-France-Other Companies

5.2.1.3 Internal Neurostimulation-France-St. Jude Medical, Inc.

5.2.1.4 Internal Neurostimulation-France-Cyberonics

5.2.1.5 Internal Neurostimulation-France-Boston Scientific

5.2.1.6 Internal Neurostimulation-France-Biocontrol Medical

5.2.1.7 Internal Neurostimulation-France-Johnson & Johnson

5.2.1.8 Internal Neurostimulation-France-Greatbatch Inc

5.2.2 Internal Neurostimulation-France, By SurgeryProcedures

5.2.2.1 Internal Neurostimulation-France-Direct Nerve Repair

5.2.2.2 Internal Neurostimulation-France-Nerve Grafting

5.2.3 Internal Neurostimulation-France, By Types

5.2.3.1 Spinal cord stimulator-France

5.2.3.2 Deep Brain Stimulator-France

5.2.3.3 Sacral Nerve Stimulator-France

5.2.3.4 Vagus Nerve Stimulator-France

5.2.3.5 Gastric Electrical stimulator-France

5.3 Internal Neurostimulation-Germany

5.3.1 Internal Neurostimulation-Germany, By Companies

5.3.1.1 Internal Neurostimulation-Germany-Medtronic, Inc.

5.3.1.2 Internal Neurostimulation-Germany-St. Jude Medical, Inc.

5.3.1.3 Internal Neurostimulation-Germany-Other Companies

5.3.1.4 Internal Neurostimulation-Germany-Boston Scientific

5.3.1.5 Internal Neurostimulation-Germany-Cyberonics

5.3.1.6 Internal Neurostimulation-Germany-Biocontrol Medical

5.3.1.7 Internal Neurostimulation-Germany-Johnson & Johnson

5.3.1.8 Internal Neurostimulation-Germany-Greatbatch Inc

5.3.2 Internal Neurostimulation-Germany, By Types

5.3.2.1 Spinal cord stimulator-Germany

5.3.2.2 Deep Brain Stimulator-Germany

5.3.2.3 Sacral Nerve Stimulator-Germany

5.3.2.4 Vagus Nerve Stimulator-Germany

5.3.2.5 Gastric Electrical stimulator-Germany

5.4 Internal Neurostimulation-Italy

5.4.1 Internal Neurostimulation-Italy, By Companies

5.4.1.1 Internal Neurostimulation-Italy-Medtronic, Inc.

5.4.1.2 Internal Neurostimulation-Italy-Other Companies

5.4.1.3 Internal Neurostimulation-Italy-St. Jude Medical, Inc.

5.4.1.4 Internal Neurostimulation-Italy-Boston Scientific

5.4.1.5 Internal Neurostimulation-Italy-Cyberonics

5.4.1.6 Internal Neurostimulation-Italy-Biocontrol Medical

5.4.1.7 Internal Neurostimulation-Italy-Johnson & Johnson

5.4.1.8 Internal Neurostimulation-Italy-Greatbatch Inc

5.4.2 Internal Neurostimulation-Italy, By Types

5.4.2.1 Spinal cord stimulator-Italy

5.4.2.2 Deep Brain Stimulator-Italy

5.4.2.3 Sacral Nerve Stimulator-Italy

5.4.2.4 Vagus Nerve Stimulator-Italy

5.4.2.5 Gastric Electrical stimulator-Italy

5.5 Internal Neurostimulation-Spain

5.5.1 Internal Neurostimulation-Spain, By Companies

5.5.1.1 Internal Neurostimulation-Spain-Medtronic, Inc.

5.5.1.2 Internal Neurostimulation-Spain-St. Jude Medical, Inc.

5.5.1.3 Internal Neurostimulation-Spain-Other Companies

5.5.1.4 Internal Neurostimulation-Spain-Boston Scientific

5.5.1.5 Internal Neurostimulation-Spain-Cyberonics

5.5.1.6 Internal Neurostimulation-Spain-Biocontrol Medical

5.5.1.7 Internal Neurostimulation-Spain-Johnson & Johnson

5.5.1.8 Internal Neurostimulation-Spain-Greatbatch Inc

5.5.2 Internal Neurostimulation-Spain, By Types

5.5.2.1 Spinal cord stimulator-Spain

5.5.2.2 Deep Brain Stimulator-Spain

5.5.2.3 Sacral Nerve Stimulator-Spain

5.5.2.4 Vagus Nerve Stimulator-Spain

5.5.2.5 Gastric Electrical stimulator-Spain

5.6 Internal Neurostimulation-Europe - Europe - Other Geographies

5.6.1 Internal Neurostimulation-Europe - Europe - Other Geographies, By Types

5.6.1.1 Spinal cord stimulator-Europe - Europe - Other Geographies

5.6.1.2 Deep Brain Stimulator-Europe - Europe - Other Geographies

5.6.1.3 Sacral Nerve Stimulator-Europe - Europe - Other Geographies

5.6.1.4 Vagus Nerve Stimulator-Europe - Europe - Other Geographies

5.6.1.5 Gastric Electrical stimulator-Europe - Europe - Other Geographies

6 Internal Neurostimulation-Europe, By Companies

6.1 Split By Geography

6.2 Internal Neurostimulation-Europe-Medtronic, Inc.

6.2.1 Internal Neurostimulation-Europe-Medtronic, Inc., By Geographies

6.2.1.1 Internal Neurostimulation-United Kingdom-Medtronic, Inc.

6.2.1.2 Internal Neurostimulation-France-Medtronic, Inc.

6.2.1.3 Internal Neurostimulation-Germany-Medtronic, Inc.

6.2.1.4 Internal Neurostimulation-Italy-Medtronic, Inc.

6.2.1.5 Internal Neurostimulation-Spain-Medtronic, Inc.

6.3 Internal Neurostimulation-Europe-Other Companies

6.3.1 Internal Neurostimulation-Europe-Other Companies, By Geographies

6.3.1.1 Internal Neurostimulation-United Kingdom-Other Companies

6.3.1.2 Internal Neurostimulation-France-Other Companies

6.3.1.3 Internal Neurostimulation-Germany-Other Companies

6.3.1.4 Internal Neurostimulation-Italy-Other Companies

6.3.1.5 Internal Neurostimulation-Spain-Other Companies

6.4 Internal Neurostimulation-Europe-St. Jude Medical, Inc.

6.4.1 Internal Neurostimulation-Europe-St. Jude Medical, Inc., By Geographies

6.4.1.1 Internal Neurostimulation-United Kingdom-St. Jude Medical, Inc.

6.4.1.2 Internal Neurostimulation-France-St. Jude Medical, Inc.

6.4.1.3 Internal Neurostimulation-Germany-St. Jude Medical, Inc.

6.4.1.4 Internal Neurostimulation-Italy-St. Jude Medical, Inc.

6.4.1.5 Internal Neurostimulation-Spain-St. Jude Medical, Inc.

6.5 Internal Neurostimulation-Europe-Cyberonics

6.5.1 Internal Neurostimulation-Europe-Cyberonics, By Geographies

6.5.1.1 Internal Neurostimulation-United Kingdom-Cyberonics

6.5.1.2 Internal Neurostimulation-France-Cyberonics

6.5.1.3 Internal Neurostimulation-Germany-Cyberonics

6.5.1.4 Internal Neurostimulation-Italy-Cyberonics

6.5.1.5 Internal Neurostimulation-Spain-Cyberonics

6.6 Internal Neurostimulation-Europe-Boston Scientific

6.6.1 Internal Neurostimulation-Europe-Boston Scientific, By Geographies

6.6.1.1 Internal Neurostimulation-United Kingdom-Boston Scientific

6.6.1.2 Internal Neurostimulation-France-Boston Scientific

6.6.1.3 Internal Neurostimulation-Germany-Boston Scientific

6.6.1.4 Internal Neurostimulation-Italy-Boston Scientific

6.6.1.5 Internal Neurostimulation-Spain-Boston Scientific

6.7 Internal Neurostimulation-Europe-Biocontrol Medical

6.7.1 Internal Neurostimulation-Europe-Biocontrol Medical, By Geographies

6.7.1.1 Internal Neurostimulation-United Kingdom-Biocontrol Medical

6.7.1.2 Internal Neurostimulation-France-Biocontrol Medical

6.7.1.3 Internal Neurostimulation-Germany-Biocontrol Medical

6.7.1.4 Internal Neurostimulation-Italy-Biocontrol Medical

6.7.1.5 Internal Neurostimulation-Spain-Biocontrol Medical

6.8 Internal Neurostimulation-Europe-Johnson & Johnson

6.8.1 Internal Neurostimulation-Europe-Johnson & Johnson, By Geographies

6.8.1.1 Internal Neurostimulation-United Kingdom-Johnson & Johnson

6.8.1.2 Internal Neurostimulation-France-Johnson & Johnson

6.8.1.3 Internal Neurostimulation-Germany-Johnson & Johnson

6.8.1.4 Internal Neurostimulation-Italy-Johnson & Johnson

6.8.1.5 Internal Neurostimulation-Spain-Johnson & Johnson

6.9 Internal Neurostimulation-Europe-Greatbatch Inc

6.9.1 Internal Neurostimulation-Europe-Greatbatch Inc, By Geographies

6.9.1.1 Internal Neurostimulation-United Kingdom-Greatbatch Inc

6.9.1.2 Internal Neurostimulation-France-Greatbatch Inc

6.9.1.3 Internal Neurostimulation-Germany-Greatbatch Inc

6.9.1.4 Internal Neurostimulation-Italy-Greatbatch Inc

6.9.1.5 Internal Neurostimulation-Spain-Greatbatch Inc

Please fill in the form below to receive a free copy of the Summary of this Report
















European Internal Neurostimulation Market

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Asian Neurostimulation/Neuromodulation devices Market Asian Neurostimulation/Neuromodulation devices Market
The Asian Neurostimulation/Neuromodulation market was expected to reach from $415.32 million in 2013 to $777.62 million by 2018 at a CAGR of 13.4%. The market divided by 2 segments such as Internal Neuromodulation and External Neuromodulation. The internal neuromodulation devices market includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), and external neuromodulation devices such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Major players in the market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.).
Upcoming
European Neurostimulation/Neuromodulation Devices Market European Neurostimulation/Neuromodulation Devices Market
The report also provides a detailed competitive landscaping of companies operating in this market. Segment- and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of major companies are detailed in the report. Boston Scientific (U.S.), Cyberonics (U.S), Medtronic, Inc. (U.S.), Depuy Synthes (Johnson & Johnson) (U.S.), and St. Jude Medical Inc. (U.S.) are some of the key players engaged in this market.
May 2015
North America Internal Neuromodulation Devices Market North America Internal Neuromodulation Devices Market
The North America neuromodulation market has been segmented by procedure, modality, and geography. On the basis of procedure, the market is further segmented into internal and external stimulation. The internal stimulation segment accounted for a share of 87.4% in the neuromodulation market. The market based on modality covers internal and external modality. The internal modality segment accounted for a share of 85.9% in the neuromodulation market.
May 2015
of items
reports | Show
Connect With Us
US/CAN : +1-888-502-0539